Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease

Clinical and Experimental Immunology

Volumn 181, Issue 1, 2015, Pages 19-28

  Bendix, M ^a   Dige, A ^a   Deleuran, B ^b   Dahlerup, J F ^a   Jorgensen S P ^c   Bartels, L E ^a   Husted, L B ^a   Harslof T ^a   Langdahl, B ^a   Agnholt, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

Crohn's disease; Flow cytometry; T cells; VDR; Vitamin D

Indexed keywords

COLECALCIFEROL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CD28 ANTIGEN; CD3 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; RETINOID X RECEPTOR ALPHA; VDR PROTEIN, HUMAN; VITAMIN D;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; TUMOR CELL LINE; YOUNG ADULT;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLACEBOS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CALCITRIOL; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER; VITAMIN D; YOUNG ADULT;

EID: 84930657874     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12613     Document Type: Article

References (38)

1. Baumgart DC, WJ, Sandborn. Crohn's disease. Lancet 2012; 380:1590-605.
2. Niessner M, BA Volk . Altered T helper type 1 (Th1)/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
3. Veny M, Esteller M, Ricart E, Pique JM, Panes J, A Salas . Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010; 31:561-72.
4. Holtta V, Klemetti P, Sipponen T et al. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis 2008; 14:1175-84.
5. de Bruyn JR, van Heeckeren R, Ponsioen CY et al. Vitamin D deficiency in Crohn' disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis 2014; 8:1267-73.
6. Bours PH, Wielders JP, Vermeijden JR, van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int 2011; 22:2857-67.
7. Ulitsky A, Ananthakrishnan AN, Naik A et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. J Parenter Enteral Nutr 2011; 35:308-16.
8. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142:482-9.
9. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009; 132:1146-60.
10. Joseph RW, Bayraktar UD, Kim TK et al. Vitamin D receptor upregulation in alloreactive human T cells. Hum Immunol 2012; 73:693-8.
11. Klopot A, Hance KW, Peleg S, Barsony J, Fleet JC. Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2. J Cell Biochem 2007; 100:617-28.
12. Ham M, Longhi MS, Lahiff C, Cheifetz A, Robson S, Moss AC. Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis 2014; 20:856-60.
13. + T cells. PLOS ONE 2014; 9:e96695.
14. Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-12.
15. Jorgensen SP, Agnholt J, Glerup H et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomised double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32:377-83.
16. Bartels LE, Bendix M, Hvas CL et al. Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients. Inflammopharmacology 2014; 22:95-103.
17. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
18. Bendix-Struve M, Bartels LE, Agnholt J, Dige A, Jorgensen SP, Dahlerup JF. Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation. Aliment Pharmacol Ther 2010; 32:1364-72.
19. Liu N, Nguyen L, Chun RF et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 2008; 149:4799-808.
20. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8.
21. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 2010; 494:166-77.
22. Wu S, Liao AP, Xia Y et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 2010; 177:686-97.
23. Wu S, YG Zhang, R Lu et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut 2014. Epub ahead of print.
24. Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol 2004; 232:137-43.
25. Harslof T, Husted LB, Carstens M et al. The expression and regulation of bone-acting cytokines in human peripheral adipose tissue in organ culture. Horm Metab Res 2011; 43:477-82.
26. Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: 0034.1-11.
27. V ON, Asani FF, Jeffery TJ, Saccone DS, Bornman L. Vitamin D receptor gene expression and function in a South African population: ethnicity, vitamin D and I. PLOS ONE 2013; 8:e67663.
28. + T cells by phage display. PLOS ONE 2011; 6:e21702.
29. Cianciolo G, La Manna G, Cappuccilli ML et al. VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif 2011; 32:161-73.
30. Prufer K, Hernandez C, Gilbreath M. Mutations in the AF-2 region abolish ligand-induced intranuclear immobilization of the liver X receptor alpha. Exp Cell Res 2008; 314:2652-60.
31. Tercel M, McManaway SP, Liyanage HD, Pruijn FB. Preparation and properties of clickable amino analogues of the duocarmycins: factors that affect the efficiency of their fluorescent labelling of DNA. ChemMedChem 2014; 9:2193-206.
32. Baeke F, Korf H, Overbergh L et al . Human T lymphocytes are direct targets of 1, 25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem Mol Biol 2010; 121:221-7.
33. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010; 11:344-9.
34. Wu-Wong JR, Nakane M, Ma J, Dixon D, Gagne G. Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells. Leuk Lymph 2006; 47:727-32.
35. Diaz L, Martinez-Reza I, Garcia-Becerra R, Gonzalez L, Larrea F, Mendez I. Calcitriol stimulates prolactin expression in non-activated human peripheral blood mononuclear cells: breaking paradigms. Cytokine 2011; 55:188-94.
36. Lin JF, Chen JM, Zuo JH et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis 2014; 20:1407-15.
37. Waldron JL, Ashby HL, Cornes MP et al. Vitamin D: a negative acute phase reactant. J Clin Pathol 2013; 66:620-2.
38. Reid D, Toole BJ, Knox S et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011; 93:1006-11.